Eve Holding, Inc. (EVEX-WT)
USD 0.5
(10.89%)
USD 0.5
(10.89%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -94.5 Million | -59.45 Million | -14.88 Million | -9.02 Million | -7.5 Million | -4.81 Million |
| Net Income | -127.65 Million | -174.03 Million | -15.86 Million | -9.62 Million | -7.68 Million | -5.04 Million |
| Depreciation & Amortization | 184 Thousand | 24.87 Thousand | 107.93 Thousand | 9056.00 | 10.69 Thousand | - |
| Deferred income taxes | -1.71 Million | - | -150.10 | 0.74 | -31.21 | - |
| Stock-based compensation | 3.29 Million | 3.3 Million | 150 Thousand | -736.00 | 31.2 Thousand | 27.6 Thousand |
| Change in working capital | 18.13 Million | 16.13 Million | 722.74 Thousand | 588.83 Thousand | 142.22 Thousand | 48.83 Thousand |
| Other non-cash items | 13.25 Million | 95.11 Million | 150.09 Thousand | -736.00 | 31.2 Thousand | 146.62 Thousand |
| Investing Cash Flow | 66.83 Million | -258.47 Million | -4.6 Million | -232.3 Million | - | - |
| Investments in PPE | -168 Thousand | -476.46 Thousand | - | - | - | - |
| Acquisitions | -219.33 Million | - | - | - | - | - |
| Investment purchases | -152.5 Million | -177 Million | - | -232.3 Million | - | - |
| Sales/Maturities of investments | 219.5 Million | - | - | - | - | - |
| Other Investing Activities | 219.33 Million | -81 Million | -4.6 Million | - | - | - |
| Financing Cash Flow | 24.92 Million | 352.7 Million | 29.26 Million | 9.02 Million | 7.5 Million | 4.81 Million |
| Debt repayment | -25.21 Million | - | - | -90.09 Thousand | - | - |
| Dividends payments | - | -1.37 Million | - | - | - | - |
| Common Stock Repurchased | -287 Thousand | - | - | - | - | - |
| Common Stock Issuance | 3000.00 | - | - | 234.67 Million | - | - |
| Other Financing Activities | -287 Thousand | 354.07 Million | 29.26 Million | -225.55 Million | 7.5 Million | 4.81 Million |
| Accounts receivables | -299 Thousand | 206.8 Thousand | -220 Thousand | - | - | - |
| Accounts payables | 2.46 Million | 1.92 Million | 30.65 Thousand | 527.37 Thousand | 99.84 Thousand | - |
| Inventory | - | -206.8 Thousand | 220 Thousand | - | - | - |
| Other working capital | 15.97 Million | 14.2 Million | 692.09 Thousand | 61.45 Thousand | 42.37 Thousand | 48.83 Thousand |
| Cash at beginning of period | 18.92 Million | 14.37 Million | 4.6 Million | 234.27 Million | - | - |
| Cash at end of period | 13.55 Million | 49.14 Million | 14.37 Million | 1.97 Million | - | - |
| Capital Expenditure | -168 Thousand | -476.46 Thousand | - | - | - | - |
| Effect of forex changes on cash | 487 Thousand | - | - | - | - | - |
| Net cash flow / Change in cash | -5.37 Million | 34.76 Million | 9.77 Million | -232.3 Million | - | - |
| Free Cash Flow | -94.67 Million | -59.93 Million | -14.88 Million | -9.02 Million | -7.5 Million | -4.81 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -35.78 Million | -36.38 Million | -25.29 Million | -127.65 Million | -39.26 Million | -31.2 Million |
| Depreciation & Amortization | 67 Thousand | 58 Thousand | 51 Thousand | 184 Thousand | 33.25 Thousand | 38.58 Thousand |
| Deferred income taxes | - | - | - | -1.71 Million | -1.71 Million | 804.62 Thousand |
| Stock-based compensation | 1.04 Million | 600 Thousand | 1.12 Million | 3.29 Million | -28.33 Thousand | 1.51 Million |
| Change in working capital | -3.77 Million | 8.86 Million | -5.09 Million | 18.13 Million | 13.18 Million | 6.43 Million |
| Other non-cash items | 7.73 Million | -4.72 Million | -2.67 Million | 13.25 Million | 3.28 Million | 22.8 Thousand |
| Investing Cash Flow | -81.23 Million | 21.34 Million | -2.1 Million | 66.83 Million | 47 Million | -12 Million |
| Investments in PPE | 765 Thousand | -659 Thousand | -106 Thousand | -168 Thousand | 56.00 | -2676.00 |
| Acquisitions | - | - | - | -219.33 Million | -47 Thousand | 12 Thousand |
| Investment purchases | -172 Million | -15 Million | -12 Million | -152.5 Million | -100 Million | -27 Million |
| Sales/Maturities of investments | -47 Million | 37 Million | 10 Million | 219.5 Million | 147 Million | 15 Million |
| Other Investing Activities | 136.99 Million | 22 Thousand | -2 Million | 219.33 Million | 47 Thousand | -12 Thousand |
| Financing Cash Flow | 108.78 Million | 14.24 Million | 14.74 Million | 24.92 Million | 14.21 Million | 11 Million |
| Debt repayment | -28.99 Million | -14.24 Million | -14.74 Million | -25.21 Million | -14.2 Million | -11 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | -287 Thousand | 0.15 | - |
| Common Stock Issuance | 94.24 Million | - | 41 Thousand | 3000.00 | 1850.00 | 1150.00 |
| Other Financing Activities | 43.52 Million | -272 Thousand | -219 Thousand | -287 Thousand | 154.00 | -375.2 Thousand |
| Accounts receivables | -544 Thousand | 338 Thousand | 206 Thousand | -299 Thousand | 1.59 Million | -1.78 Million |
| Accounts payables | 1.13 Million | 1.2 Million | -2.9 Million | 2.46 Million | 2.71 Million | -458.35 Thousand |
| Inventory | - | - | - | - | -1.89 Million | 1.78 Million |
| Other working capital | -4.93 Million | 7.32 Million | -2.38 Million | 15.97 Million | 8.86 Million | 6.89 Million |
| Cash at beginning of period | 23.76 Million | 18.13 Million | 42.49 Million | 18.92 Million | 10.09 Million | 33.59 Million |
| Cash at end of period | 24.57 Million | 23.76 Million | 18.13 Million | 13.55 Million | 13.55 Million | 10.09 Million |
| Capital Expenditure | 765 Thousand | -659 Thousand | -106 Thousand | -168 Thousand | 56.00 | -2676.00 |
| Effect of forex changes on cash | -13 Thousand | -657 Thousand | -122 Thousand | 487 Thousand | 85.33 Thousand | -100.41 Thousand |
| Net cash flow / Change in cash | 805 Thousand | 5.63 Million | -24.36 Million | -5.37 Million | 3.46 Million | -23.49 Million |
| Free Cash Flow | -29.95 Million | -31.41 Million | -35.91 Million | -94.67 Million | -24.51 Million | -22.39 Million |
PPPM
6724
JUBLPHARMA
IOB
LAUR
3991